Catterton Tries Its Luck On "Stretch-Mark Cream Turned Anti-Wrinkle Phenom"
This article was originally published in The Rose Sheet
Executive Summary
Private equity firm Catterton Partners augments its cosmeceutical portfolio with the acquisition of an early trailblazer across the cosmetics/pharmaceuticals frontier, StriVectin